NorthRock Partners LLC Has $590,000 Stake in Agilent Technologies, Inc. (NYSE:A)

NorthRock Partners LLC grew its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 151.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,394 shares of the medical research company's stock after purchasing an additional 2,648 shares during the period. NorthRock Partners LLC's holdings in Agilent Technologies were worth $590,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. CKW Financial Group lifted its holdings in Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock worth $25,000 after acquiring an additional 100 shares during the last quarter. Global X Japan Co. Ltd. lifted its holdings in shares of Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock worth $25,000 after purchasing an additional 116 shares during the last quarter. Redwood Park Advisors LLC bought a new stake in shares of Agilent Technologies in the 4th quarter worth approximately $27,000. Lee Danner & Bass Inc. bought a new stake in shares of Agilent Technologies in the 4th quarter worth approximately $29,000. Finally, Hanson & Doremus Investment Management lifted its holdings in shares of Agilent Technologies by 66.5% in the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock worth $35,000 after purchasing an additional 105 shares during the last quarter. 87.42% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Barclays cut their target price on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. TD Cowen upped their target price on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Thursday, April 10th. Wells Fargo & Company cut their price target on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating on the stock in a report on Thursday, April 17th. Jefferies Financial Group decreased their price objective on Agilent Technologies from $135.00 to $116.00 and set a "hold" rating for the company in a report on Monday, April 21st. Finally, Robert W. Baird cut their target price on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a research note on Thursday, February 27th. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $143.00.

Agilent Technologies Price Performance

NYSE:A traded down $0.45 during mid-day trading on Monday, reaching $113.32. 1,965,787 shares of the stock were exchanged, compared to its average volume of 1,904,845. The business has a fifty day moving average price of $110.44 and a 200 day moving average price of $128.16. The firm has a market capitalization of $32.31 billion, a PE ratio of 26.05, a PEG ratio of 3.21 and a beta of 1.27. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $154.95. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. Research analysts expect that Agilent Technologies, Inc. will post 5.54 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st were paid a $0.248 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.88%. Agilent Technologies's dividend payout ratio is currently 22.76%.

Insider Buying and Selling

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the firm's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now directly owns 21,786 shares in the company, valued at approximately $2,657,456.28. This trade represents a 8.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the sale, the director now owns 35,737 shares of the company's stock, valued at $4,161,931.02. The trade was a 4.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.26% of the stock is currently owned by company insiders.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.